It contained maternal demographics (age, parity, blood pressure, PE, gestational hypertension), fetal biometric (estimated fetal weight) and Doppler measurements (middle cerebral artery, umbilical artery) and maternal angiogenic biomarkers (PlGF, soluble endoglin (sEng), sFlt-1 and sFlt-1/PlGF ratio). The gene discussed is ENG; the disease is preeclampsia.